Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2012

01.09.2012 | Clinical Study

Resection of gliomas in the cingulate gyrus: functional outcome and survival

verfasst von: Ági Oszvald, Johanna Quick, Kea Franz, Erdem Güresir, Andrea Szelényi, Hartmut Vatter, Volker Seifert

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Functional outcome after resection of tumors arising from the gyrus cinguli (GC), part of the limbic system, is not well analyzed. The purpose of this study was to evaluate the feasibility and functional outcome of surgical treatment for a series of 65 patients with gliomas involving the GC. Preoperative data, extent of resection, functional outcome (Karnofsky performance index, KPI, and the National Institute of Health Stroke Scale, NIHSS), and survival of 65 patients with gliomas arising from the GC were analyzed on the basis of a prospectively conducted database of gliomas between 06/1999 and 07/2010. Extent of resection (complete, subtotal, or partial) was based on early postoperative MRI. Eighty-six percent of the gliomas were located in the anterior part of the GC and 14 % in the posterior part. Fifty-five percent of the patients presented with seizures and 17 % with hemiparesis (mean preoperative KPI = 86 ± 17, NIHSS = 1.4 ± 1.7). Histologically, the tumors were WHO Grade II in 25 %, Grade III in 26 %, and Grade IV in 49 %. Complete resection was achieved for 59 %, subtotal resection for 32%, and partial resection for 9 %. Postoperative transient deficits included SMA lesion (14 %) and new or worsened hemiparesis (8 %), which resolved within 30 days (NIHSS early postoperatively 1.7 ± 1.4, late postoperatively 0.8 ± 1.4, and after 6 months 0.6 ± 1.4). According to histopathological grading, median survival was 67 months (WHO°II), 87 months (WHO°III), and 16.5 months (WHO°IV), and overall survival was 34 months. Microsurgical resection of gliomas arising from the GC is feasible; gross total resection can be achieved for 90 % of gliomas arising from the GC with 5 % long-term morbidity.
Literatur
1.
Zurück zum Zitat Israel M, Steiger H, Kolivakis T, McGregor L, Sadikot AF (2010) Deep brain stimulation in the subgenual cingulate cortex for an intractable eating disorder. Biol Psychiatry 67:e53–e54PubMedCrossRef Israel M, Steiger H, Kolivakis T, McGregor L, Sadikot AF (2010) Deep brain stimulation in the subgenual cingulate cortex for an intractable eating disorder. Biol Psychiatry 67:e53–e54PubMedCrossRef
2.
Zurück zum Zitat Lacroix M, bi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198PubMedCrossRef Lacroix M, bi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198PubMedCrossRef
3.
Zurück zum Zitat Paus T (2001) Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci 2:417–424PubMedCrossRef Paus T (2001) Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci 2:417–424PubMedCrossRef
4.
Zurück zum Zitat Richter EO, Davis KD, Hamani C, Hutchison WD, Dostrovsky JO, Lozano AM (2008) Cingulotomy for psychiatric disease: microelectrode guidance, a callosal reference system for documenting lesion location, and clinical results. Neurosurgery 62:957–965PubMedCrossRef Richter EO, Davis KD, Hamani C, Hutchison WD, Dostrovsky JO, Lozano AM (2008) Cingulotomy for psychiatric disease: microelectrode guidance, a callosal reference system for documenting lesion location, and clinical results. Neurosurgery 62:957–965PubMedCrossRef
5.
Zurück zum Zitat Rushworth MF, Buckley MJ, Behrens TE, Walton ME, Bannerman DM (2007) Functional organization of the medial frontal cortex. Curr Opin Neurobiol 17:220–227PubMedCrossRef Rushworth MF, Buckley MJ, Behrens TE, Walton ME, Bannerman DM (2007) Functional organization of the medial frontal cortex. Curr Opin Neurobiol 17:220–227PubMedCrossRef
6.
Zurück zum Zitat Steele JD, Christmas D, Eljamel MS, Matthews K (2008) Anterior cingulotomy for major depression: clinical outcome and relationship to lesion characteristics. Biol Psychiatry 63:670–677PubMedCrossRef Steele JD, Christmas D, Eljamel MS, Matthews K (2008) Anterior cingulotomy for major depression: clinical outcome and relationship to lesion characteristics. Biol Psychiatry 63:670–677PubMedCrossRef
7.
Zurück zum Zitat Steiger HJ, Goppert M, Floeth F, Turowski B, Sabel M (2009) Fronto-mesial WHO grade II and III gliomas: specific aspects of tumours arising from the anterior cingulate gyrus. Acta Neurochir (Wien) 151:137–140CrossRef Steiger HJ, Goppert M, Floeth F, Turowski B, Sabel M (2009) Fronto-mesial WHO grade II and III gliomas: specific aspects of tumours arising from the anterior cingulate gyrus. Acta Neurochir (Wien) 151:137–140CrossRef
8.
Zurück zum Zitat Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564–576PubMedCrossRef Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564–576PubMedCrossRef
9.
Zurück zum Zitat Talacchi A, Corsini F, Gerosa M (2010) Surgical approaches to tumors of the anterior gyrus cinguli. Neurosurgery 66:245–251PubMedCrossRef Talacchi A, Corsini F, Gerosa M (2010) Surgical approaches to tumors of the anterior gyrus cinguli. Neurosurgery 66:245–251PubMedCrossRef
10.
Zurück zum Zitat Tate MC, Kim CY, Chang EF, Polley MY, Berger MS (2010) Assessment of morbidity following resection of cingulate gyrus gliomas. J Neurosurg 114:640–647 Tate MC, Kim CY, Chang EF, Polley MY, Berger MS (2010) Assessment of morbidity following resection of cingulate gyrus gliomas. J Neurosurg 114:640–647
11.
Zurück zum Zitat Vogt BA (2005) Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci 6:533–544PubMedCrossRef Vogt BA (2005) Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci 6:533–544PubMedCrossRef
12.
Zurück zum Zitat von Lehe M, Schramm J (2009) Gliomas of the cingulate gyrus: surgical management and functional outcome. Neurosurg Focus 27:E9CrossRef von Lehe M, Schramm J (2009) Gliomas of the cingulate gyrus: surgical management and functional outcome. Neurosurg Focus 27:E9CrossRef
13.
Zurück zum Zitat Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27:5874–5880PubMedCrossRef Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27:5874–5880PubMedCrossRef
14.
Zurück zum Zitat Yasargil MG, Ture U, Yasargil DC (2005) Surgical anatomy of supratentorial midline lesions. Neurosurg Focus 18:E1PubMedCrossRef Yasargil MG, Ture U, Yasargil DC (2005) Surgical anatomy of supratentorial midline lesions. Neurosurg Focus 18:E1PubMedCrossRef
15.
Zurück zum Zitat Yen CP, Kuan CY, Sheehan J, Kung SS, Wang CC, Liu CK, Kwan AL (2009) Impact of bilateral anterior cingulotomy on neurocognitive function in patients with intractable pain. J Clin Neurosci 16:214–219PubMedCrossRef Yen CP, Kuan CY, Sheehan J, Kung SS, Wang CC, Liu CK, Kwan AL (2009) Impact of bilateral anterior cingulotomy on neurocognitive function in patients with intractable pain. J Clin Neurosci 16:214–219PubMedCrossRef
Metadaten
Titel
Resection of gliomas in the cingulate gyrus: functional outcome and survival
verfasst von
Ági Oszvald
Johanna Quick
Kea Franz
Erdem Güresir
Andrea Szelényi
Hartmut Vatter
Volker Seifert
Publikationsdatum
01.09.2012
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2012
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-012-0898-0

Weitere Artikel der Ausgabe 2/2012

Journal of Neuro-Oncology 2/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.